查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫療器材報銷市場 - 按付款人（公共、私人）、醫療機構（醫院、門診設施）和預測，2023 年至 2032 年
市場調查報告書
商品編碼
1351517

醫療器材報銷市場 - 按付款人（公共、私人）、醫療機構（醫院、門診設施）和預測，2023 年至 2032 年

Medical Devices Reimbursement Market - By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities) & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

在多個經濟體有利的監管環境的推動下，2023 年至 2032 年間，全球醫療器材報銷市場規模將以 7.3% 的複合年成長率擴大。監管環境顯著影響醫療器材報銷。政府機構，例如美國 FDA 和歐洲藥品管理局 (EMA)，制定醫療器材的核准和報銷途徑。

法規的變化，包括核准流程、標籤要求和上市後監督，可以直接影響設備製造商的報銷策略，從而促進市場的成長和發展。例如，法國衛生部的 Louisa Stuwe 表示，2023 年 7 月，法國用於遠端患者監測和數位治療的數位設備現在有資格獲得快速存取和報銷，這一過程與德國的 DiGA 計劃相似。

整個醫療器材報銷市場根據付款人、醫療保健環境和地區進行分類。

私人付款人從 2023 年到 2032 年的複合年成長率可能達到 7%，並由於能夠提供更大的靈活性和客製化的核保選項，到 2032 年將主導醫療器材報銷市場佔有率。與政府資助的計畫通常有嚴格的法規和有限的預算不同，私人付款人可以快速適應新技術和療法。這種適應性吸引了尋求全面覆蓋的患者和尋求更快報銷流程的設備製造商，推動了醫療設備報銷領域中私人付款人參與的激增。

到 2032 年，醫療器材報銷行業的門診設施部分的複合年成長率可能會達到 7.9%。在門診環境中提供先進的微創手術的趨勢日益明顯，這增加了對可報銷醫療器材的需求。此外，門診設施比醫院更具成本效益，這使其成為對患者和付款人都有吸引力的選擇。因此，對門診護理的需求不斷成長，推動了對醫療設備報銷解決方案的需求，以支持這些不斷發展的醫療保健服務模式。

歐洲醫療器材報銷產業2023-2032年將呈現7%的成長率。醫療保健支出的增加、人口老化以及慢性病盛行率的增加正在推動對創新醫療技術的需求。歐洲各國政府也在改革報銷政策，以方便取得尖端醫療設備。此外，數位健康解決方案的成長和對基於價值的護理模式的更加重視正在促進整個歐洲醫療器材報銷行業的擴張。

目錄

第 1 章：方法論

  • 行業覆蓋
  • 市場範圍和定義
  • 基本估算和工作
    • 數據採集
  • 預測參數
  • COVID-19 對全球的影響
  • 數據驗證
  • 資料來源
    • 基本的
    • 中學
      • 付費來源
      • 無償來源

第 2 章：執行摘要

第 3 章：醫療器材報銷產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 各種慢性病盛行率不斷上升
      • 人口老化加劇
      • 醫療費用負擔日益加重
      • 支持性政府計劃
    • 產業陷阱與挑戰
      • 複雜的框架
      • 有限的承保範圍和報銷設施
  • 成長潛力分析
    • 按付款人
    • 按醫療保健環境
  • COVID-19 影響分析
  • 監管環境
  • 技術景觀
  • 未來市場趨勢
  • 政策舉措
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局，2022 年

  • 介紹
  • 2022 年公司矩陣分析
  • 競爭定位矩陣
  • 供應商矩陣分析
  • 2022 年公司市佔率分析
  • 策略儀表板，2022 年

第 5 章：醫療器材報銷市場規模與預測：按付款人

  • 主要付款人趨勢
  • 民眾
  • 私人的

第 6 章：醫療器材報銷市場規模與預測：按醫療保健環境

  • 主要醫療保健環境趨勢
  • 醫院
  • 門診設施
  • 其他

第 7 章：醫療器材報銷市場規模及預測：按地區

  • 主要區域趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 波蘭
    • 瑞典
    • 荷蘭人
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 印尼
    • 菲律賓
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
  • MEA
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 土耳其
    • 以色列
    • 伊朗

第 8 章：公司簡介

  • CVS Health
  • BNP Paribas
  • Aviva
  • Cigna
  • United Health Group
  • Allianz
  • Aetna
  • Humana Inc.
  • WellCare Health Plans, Inc.
  • Nippon Life Insurance Company
  • Anthem Insurance Companies, Inc.
Product Code: 6175

Global Medical Devices Reimbursement Market size will expand at 7.3% CAGR between 2023 and 2032, driven by the favorable regulatory environment across several economies. The regulatory landscape significantly impacts medical device reimbursement. Government agencies, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, establish the approval and reimbursement pathways for medical devices.

Changes in regulations, including the approval process, labeling requirements, and post-market surveillance, can directly impact reimbursement strategies for device manufacturers, leading to market growth and development. For instance, in July 2023, digital devices for remote patient monitoring and digital therapeutics in France are now eligible for expedited access and reimbursement, a process that bears similarities to Germany's DiGA program, as stated by Louisa Stuwe from the French Ministry of Health.

The overall medical devices reimbursement market is segregated based on payer, healthcare setting, and region.

Private payers could register a 7% CAGR from 2023 to 2032 and dominate the medical devices reimbursement market share by 2032 due to their ability to offer more flexibility and customized coverage options. Unlike government-funded programs that often have stringent regulations and limited budgets, private payers can adapt quickly to new technologies and therapies. This adaptability attracts both patients seeking comprehensive coverage and device manufacturers looking for faster reimbursement processes, driving the surge in private payer participation within the medical device reimbursement landscape.

The outpatient facilities segment of the medical devices reimbursement industry could expand at 7.9% CAGR through 2032. There is a growing trend toward providing advanced, minimally invasive procedures in outpatient settings, increasing the need for reimbursable medical devices. Additionally, outpatient facilities are more cost-effective than hospitals, making them an attractive option for both patients and payers. As a result, the increasing demand for outpatient care is fueling the need for medical device reimbursement solutions to support these evolving healthcare delivery models.

Europe medical device reimbursement industry will exhibit a 7% growth rate throughout 2023-2032. Rising healthcare expenditures, an aging population, and the increasing prevalence of chronic diseases are driving demand for innovative medical technologies. European governments are also reforming reimbursement policies to facilitate access to cutting-edge medical devices. Furthermore, the growth of digital health solutions and greater emphasis on value-based care models are contributing to the expansion of the medical device reimbursement sector across Europe.

Table of Contents

Chapter 1 Methodology

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Payer trends
    • 2.1.4 Healthcare setting trends

Chapter 3 Medical Devices Reimbursement Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of various chronic diseases
      • 3.2.1.2 Rising aging population
      • 3.2.1.3 Growing burden of healthcare cost
      • 3.2.1.4 Supportive government programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Complex framework
      • 3.2.2.2 Limited coverage and reimbursement facilities
  • 3.3 Growth potential analysis
    • 3.3.1 By payer
    • 3.3.2 By healthcare setting
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 Latin America
    • 3.5.5 MEA
  • 3.6 Technology landscape
  • 3.7 Future market trends
  • 3.8 Policy initiatives
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix
  • 4.4 Vendor matrix analysis
  • 4.5 Company market share analysis, 2022
  • 4.6 Strategy dashboard, 2022

Chapter 5 Medical Devices Reimbursement Market Size and Forecast, By Payer (USD Billion)

  • 5.1 Key payer trends
  • 5.2 Public
  • 5.3 Private

Chapter 6 Medical Devices Reimbursement Market Size and Forecast, By Healthcare Setting (USD Billion)

  • 6.1 Key healthcare setting trends
  • 6.2 Hospitals
  • 6.3 Outpatient facilities
  • 6.4 Others

Chapter 7 Medical Devices Reimbursement Market Size and Forecast, By Region (USD Billion)

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Poland
    • 7.3.7 Sweden
    • 7.3.8 The Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Philippines
    • 7.4.8 Vietnam
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Columbia
    • 7.5.5 Chile
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Turkey
    • 7.6.5 Israel
    • 7.6.6 Iran

Chapter 8 Company Profiles

  • 8.1 CVS Health
  • 8.2 BNP Paribas
  • 8.3 Aviva
  • 8.4 Cigna
  • 8.5 United Health Group
  • 8.6 Allianz
  • 8.7 Aetna
  • 8.8 Humana Inc.
  • 8.9 WellCare Health Plans, Inc.
  • 8.10 Nippon Life Insurance Company
  • 8.11 Anthem Insurance Companies, Inc.

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by payer (2022)
  • TABLE 3 Market revenue, by healthcare setting (2022)
  • TABLE 4 Market revenue, by region (2022)
  • TABLE 5 Global medical devices reimbursement market, 2018 - 2024 (USD Billion)
  • TABLE 6 Global medical devices reimbursement market, 2025 - 2032 (USD Billion)
  • TABLE 7 Global medical devices reimbursement market, by region, 2018 - 2024 (USD Billion)
  • TABLE 8 Global medical devices reimbursement market, by region, 2025 - 2032 (USD Billion)
  • TABLE 9 Global medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 10 Global medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 11 Global medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 12 Global medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 13 Industry impact forces
  • TABLE 14 Public market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 15 Public market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 16 Private market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 17 Private market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 18 Hospitals market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 19 Hospitals market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 20 Outpatient facilities market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 21 Outpatient facilities market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 22 Others market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 23 Others market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 24 North America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 25 North America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 26 North America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 27 North America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 28 North America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 29 North America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 30 U.S. medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 31 U.S. medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 32 U.S. medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 33 U.S. medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 34 Canada medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 35 Canada medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 36 Canada medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 37 Canada medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 38 Europe medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 39 Europe medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 40 Europe medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 41 Europe medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 42 Europe medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 43 Europe medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 44 Germany medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 45 Germany medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 46 Germany medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 47 Germany medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 48 UK medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 49 UK medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 50 UK medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 51 UK medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 52 France medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 53 France medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 54 France medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 55 France medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 56 Spain medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 57 Spain medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 58 Spain medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 59 Spain medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 60 Italy medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 61 Italy medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 62 Italy medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 63 Italy medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 64 Poland medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 65 Poland medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 66 Poland medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 67 Poland medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 68 Sweden medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 69 Sweden medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 70 Sweden medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 71 Sweden medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 72 The Netherlands medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 73 The Netherlands medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 74 The Netherlands medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 75 The Netherlands medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 76 Asia Pacific medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 77 Asia Pacific medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 78 Asia Pacific medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 79 Asia Pacific medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 80 Asia Pacific medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 81 Asia Pacific medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 82 China medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 83 China medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 84 China medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 85 China medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 86 Japan medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 87 Japan medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 88 Japan medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 89 Japan medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 90 India medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 91 India medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 92 India medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 93 India medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 94 Australia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 95 Australia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 96 Australia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 97 Australia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 98 South Korea medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 99 South Korea medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 100 South Korea medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 101 South Korea medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 102 Indonesia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 103 Indonesia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 104 Indonesia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 105 Indonesia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 106 Philippines medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 107 Philippines medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 108 Philippines medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 109 Philippines medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 110 Vietnam medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 111 Vietnam medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 112 Vietnam medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 113 Vietnam medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 114 Latin America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 115 Latin America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 116 Latin America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 117 Latin America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 118 Latin America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 119 Latin America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 120 Brazil medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 121 Brazil medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 122 Brazil medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 123 Brazil medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 124 Mexico medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 125 Mexico medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 126 Mexico medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 127 Mexico medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 128 Argentina medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 129 Argentina medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 130 Argentina medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 131 Argentina medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 132 Columbia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 133 Columbia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 134 Columbia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 135 Columbia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 136 Peru medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 137 Peru medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 138 Peru medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 139 Peru medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 140 Chile medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 141 Chile medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 142 Chile medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 143 Chile medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 144 MEA medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 145 MEA medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 146 MEA medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 147 MEA medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 148 MEA medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 149 MEA medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 150 South Africa medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 151 South Africa medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 152 South Africa medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 153 South Africa medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 154 Saudi Arabia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 155 Saudi Arabia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 156 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 157 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 158 UAE medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 159 UAE medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 160 UAE medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 161 UAE medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 162 Turkey medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 163 Turkey medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 164 Turkey medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 165 Turkey medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 166 Israel medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 167 Israel medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 168 Israel medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 169 Israel medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 170 Iran medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 171 Iran medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 172 Iran medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 173 Iran medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
  • FIG. 7 Industry landscape, 2018 - 2032 (USD Billion)
  • FIG. 8 Growth potential analysis, by payer
  • FIG. 9 Growth potential analysis, by healthcare setting
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company matrix analysis, 2022
  • FIG. 13 Competitive positioning matrix
  • FIG. 14 Vendor matrix analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 Strategy dashboard, 2022